NCT05822063

Brief Summary

Compare the effects of lidocaine ,ice packs and flash lights on the intensity of pain induced by arteriovenous cannulation in hemodialysis patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jul 2023

Shorter than P25 for phase_3

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

July 25, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

July 20, 2023

Status Verified

July 1, 2023

Enrollment Period

1 month

First QC Date

April 6, 2023

Last Update Submit

July 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual analogue scale(VAS)

    it is score 1 to 10 according to pain intensity( 1= better ,10= worst)

    one month ( 30 days)

Study Arms (4)

Lidocaine group

ACTIVE COMPARATOR

the skin site will be prepped first and then two puffs of lidocaine (20 mg) will be sprayed by the researcher from a 5-cm distance on the dermal surface near the needle insertion point. Five minutes after spraying, the skin surface at the site of arterial needle insertion will be disinfected with 70% alcohol-soaked cotton pads and the specific hemodialysis needles will be inserted into the vessels of the fistula area by the ward nurse

Drug: Lidocaine topical

cold packs

ACTIVE COMPARATOR

In the ice pack method, 5 pieces of ice measuring 5\*5 will be placed in latex gloves and covered with material cover. They were placed after the passage of 2 min on the hand at the site of fistula 5 min before making the puncture. Next, specific hemodialysis needles will be inserted in the vessels of fistula area by the ward nurse after disinfecting the fistula area with 70% alcohol-soaked cotton pads.

Other: cold packs

flash lights

ACTIVE COMPARATOR

the patient's face will be photographed. The photograph will be taken with a camera \[(Sony HVLHFL1 with luminance intensity approximately 100 cd, lighting distance approximately 11 Lux, flash shooting distance (1-5 m)\].

Device: flash lights

control

NO INTERVENTION

no intervention

Interventions

lidocaine spray

Also known as: lidocaine spray
Lidocaine group

ice packs

cold packs

flash lights by camera

flash lights

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who will be willing to participate in the study.
  • Patients who are diagnosed as chronic kidney disease \& undergoing haemodialysis with A.V. fistula of upper extremity currently used for haemodialysis which can be radio cephalic, radio basilic or brachio cephalic.
  • Chronic kidney disease patients who are visiting regularly, minimum 2 times per week for haemodialysis.

You may not qualify if:

  • \. Chronic kidney disease patients who are undergoing haemodialysis with other vascular access than A.V. fistula access.
  • \. Patients who are allergic to cold therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Lidocaine

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer in clinical pharmacy

Study Record Dates

First Submitted

April 6, 2023

First Posted

April 20, 2023

Study Start

July 25, 2023

Primary Completion

August 25, 2023

Study Completion

September 1, 2023

Last Updated

July 20, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share